Editorial overview
5-HT: The promiscuous and happy hormone!

https://doi.org/10.1016/j.coph.2011.03.001Get rights and content

Section snippets

Professor Nicholas Barnes has been a member of the Faculty of the University of Birmingham Medical School for 21 years and holds the Chair in Neuropharmacology. He is Director of the Cellular and Molecular Neuropharmacology Research Group; the group's principal research interest is 5-HT (5-hydroxytryptamine, serotonin). In addition, Professor Barnes is co-Chairman of the International Union of Basic and Clinical Pharmacology (IUPHAR) Nomenclature Committee for Serotonin Receptors. He is also

References (0)

Cited by (10)

View all citing articles on Scopus

Professor Nicholas Barnes has been a member of the Faculty of the University of Birmingham Medical School for 21 years and holds the Chair in Neuropharmacology. He is Director of the Cellular and Molecular Neuropharmacology Research Group; the group's principal research interest is 5-HT (5-hydroxytryptamine, serotonin). In addition, Professor Barnes is co-Chairman of the International Union of Basic and Clinical Pharmacology (IUPHAR) Nomenclature Committee for Serotonin Receptors. He is also Editor-in-Chief, Executive Editor and Associate Editor for the international journals Frontiers in Neuropharmacology, Neuropharmacology, and Frontiers in Neuroscience, respectively.

Professor Barnes is also a member of the working group that advises the UK Government on issues concerning the misuse of drugs and polysubstance abuse.

In addition to his academic-related positions, Professor Barnes is a founder and CEO of Celentyx Ltd.; a pharmaceutical research and development company with a therapeutic focus on immune system disorders.

View full text